royalties
uniQure announces sale of royalty interest in Hemgenix for up to $400m
May 16, 2023Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure
uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …
AstraZeneca sells off three drugs in deal worth $350 million
November 6, 2018Manufacturing and Production AstraZeneca, asthma, covis, deal, royalties
Anglo-Swedish multinational AstraZeneca has agreed to sell the rights to three asthma and rhinitis drugs in a deal worth $350 …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
